63
https://pubmed.ncbi.nlm.nih.gov/38117951
The abstract reports the discovery and optimization of a new DNA-PK inhibitor, compound 31t, which shows potent and selective inhibition of DNA-PK, favorable pharmacokinetic properties, and promising cancer cell growth inhibition in xenograft models.